Physiological effects of adding ECCO₂R to invasive mechanical ventilation for COPD exacerbations

Area of Science:

• Critical Care Medicine
• Pulmonary Medicine
• Respiratory Physiology

Background:

• Severe acute exacerbations (AE) of COPD often necessitate invasive mechanical ventilation (IMV).
• Extracorporeal CO2 removal (ECCO2R) is a potential adjunctive therapy to IMV for AE-COPD patients.
• The impact of low-to-middle flow ECCO2R on gas exchange and respiratory mechanics during weaning requires further investigation.

Purpose of the Study:

• To evaluate the effects of ECCO2R on gas exchange and dynamic hyperinflation in AE-COPD patients undergoing IMV.
• To assess the impact of ECCO2R on the work of breathing (WOB) during the IMV weaning process.
• To determine the efficacy of a specific respiratory rate adjustment algorithm combined with ECCO2R.

Main Methods:

• An open prospective interventional study was conducted on 12 deeply sedated AE-COPD patients.
• ECCO2R was initiated using a low-to-middle flow device (Hemolung) with a tailored respiratory rate adjustment algorithm.
• Gas exchange, dynamic hyperinflation (intrinsic PEEP, FRC), and WOB were measured before and after ECCO2R initiation and during weaning.

Main Results:

• ECCO2R significantly improved arterial PCO2 (PaCO2) and pH levels.
• No significant changes were observed in intrinsic PEEP or Functional Residual Capacity (FRC) across the group.
• A trend towards decreased WOB was noted after stopping ECCO2R during weaning, though not statistically significant.

Conclusions:

• ECCO2R, with a formalized RR adjustment protocol, effectively improved gas exchange in AE-COPD patients on IMV.
• ECCO2R did not significantly reduce dynamic hyperinflation in this patient cohort.
• A potential benefit of reduced WOB during weaning warrants further investigation in larger studies.